Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Stocks
Currencies
Cryptocurrencies
Metals
Indices
Commodities
ETFs
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
News
Top Providers News
Top Providers News
Symbols
Market
Provider
Time
Symbols
News
Provider
2026.11.03
Qatar's Foreign Ministry Spokesperson Announces Progress In Talks With Both Sides
Benzinga
2026.11.03
Driven Brands Discloses Material Errors In Its FY25, FY24 And FY23 Consolidated Financial Statements, Along With Quarterly And YtD Periods In FY25 And FY24, As Well As Quarterly And YtD Periods Ended June 27, 2026 And March 28, 2026; Delays Q3 Earnings...
Benzinga
2026.11.03
Seres Therapeutics Announces Publication Of Results From Phase 1b Clinical Study Of SER-155 In Adults Undergoing Allogeneic Hematopoietic Cell Transplantation In Nature Medicine Issue
Benzinga
2026.11.03
STAK Appoints Xiaofei Han CFO, Effective Nov. 1
Benzinga
2026.11.03
Disney Targets Thousands of Jobs in Fresh Cost-Cutting Blitz: Report
Benzinga
2026.11.03
Alkermes Q3 EPS $0.09 Beats $(0.06) Estimate, Sales $480.100M Beat $463.606M Estimate
Benzinga
2026.11.03
Envoy Announces Expansion Into Southwest Florida With Launch Of On-Site EV Car Sharing At $100M Midtown Redevelopment
Benzinga
2026.11.03
Needham Maintains Buy on Ichor Holdings, Lowers Price Target to $55
Benzinga
2026.11.03
Teva Pharmaceutical Indus Raises FY2026 Adj EPS Guidance from $1.91-$2.11 to $1.92-$2.11 vs $1.98 Est; Raises FY2026 Sales Guidance from $16.500B-$16.850B to $16.700B-$17.000B vs $16.651B Est
Benzinga
2026.11.03
Beam Therapeutics Q3 EPS $(1.28) Misses $(1.15) Estimate, Sales $307.000K Miss $8.752M Estimate
Benzinga
2026.11.03
Baird Maintains Outperform on Ethos Technologies, Raises Price Target to $55
Benzinga
2026.11.03
Alkermes Affirms FY2026 Sales Guidance of $1.730B-$1.840B vs $1.822B Est
Benzinga
2026.11.03
UnitedHealth, Cleveland-Cliffs, Regeneron Pharmaceuticals And More: CNBC’s ‘Final Trades’
Benzinga
2026.11.03
Cantor Fitzgerald Maintains Overweight on EMCOR Group, Lowers Price Target to $920
Benzinga
2026.11.03
Is BlackRock Selling Bitcoin? What's Really Behind the $405 Million IBIT Outflow
BeInCrypto
2026.11.03
Morgan Stanley Maintains Equal-Weight on Palantir Technologies, Raises Price Target to $233
Benzinga
2026.11.03
TransAlta Q3 Adj. EPS $0.13 Beats $0.05 Estimate, Sales $383.026M Down From $439.479M YoY
Benzinga
2026.11.03
TransAlta Q3 Adj. EPS $0.18 Beats $0.07 Estimate, Sales $536.000M Down From $615.000M YoY
Benzinga
2026.11.03
JP Morgan Upgrades Cloudflare to Overweight, Maintains Price Target to $350
Benzinga
2026.11.03
CorVel Q2 EPS $0.67 Up From $0.54 YoY, Sales $267.129M Up From $239.643M YoY
Benzinga
2026.11.03
Robo.ai Unit Neurovia AI Presents On Sovereign AI And National Data Infrastructure At Abu Dhabi Government AI Summit
Benzinga
2026.11.03
IDEAYA Biosciences Q3 EPS $(1.22) Misses $(1.18) Estimate, Sales $10.242M Beat $6.857M Estimate
Benzinga
2026.11.03
Enlight Renewable Energy Raises FY2026 Sales Guidance from $790.000M-$820.000M to $810.000M-$830.000M
Benzinga
2026.11.03
Clarivate Lowers FY2026 GAAP EPS Guidance from $(0.64)-$(0.54) to $(0.65)-$(0.62) vs $(0.46) Est
Benzinga
2026.11.03
Clarivate Sees Q4 Adj EPS $0.14-$0.18 vs $0.19 Est; Sees Sales $490.000M-$510.000M vs $562.824M Est
Benzinga
2026.11.03
BMO Capital Upgrades Aon to Outperform, Raises Price Target to $380
Benzinga
2026.11.03
Clarivate Narrows FY2026 Adj EPS Guidance from $0.70-$0.80 to $0.73-$0.77 vs $0.74 Est; Lowers FY2026 Sales Guidance from $2.300B-$2.420B to $1.965B-$1.985B vs $2.304B Est
Benzinga
2026.11.03
Cantor Fitzgerald Initiates Coverage On Trex Bio with Overweight Rating
Benzinga
2026.11.03
Ted Lieu Slams Trump Over 'Trump Reflecting Pool' Rename Idea as Americans Face Rising Costs: 'What are Trump and His...'
Benzinga
2026.11.03
Amneal Pharmaceuticals Raises FY2026 Adj EPS Guidance from $0.96-$1.06 to $1.04-$1.08 vs $1.03 Est; Raises FY2026 Sales Guidance from $3.100B-$3.200B to $3.150B-$3.250B vs $3.159B Est
Benzinga
1
...
307
308
309
310
311
312
...
709
>